Biphasic development of carrageenin edema in rats.
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D001831:Body Temperature; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced* / Q000188:drug therapy; D005528:Foot; D006854:Hydrocortisone / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D008297:Male; D010653:Phenylbutazone / Q000627:therapeutic use; D051381:Rats; D012867:Skin; D013997:Time Factors
D002351:Carrageenan; D010653:Phenylbutazone; D001241:Aspirin; D006854:Hydrocortisone; D007213:Indomethacin